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Abstract 
 
Background: Authors were assigned the task to develop case definitions for periodontitis in the 
context of the 2017 World Workshop on Classification of Periodontal and Peri-Implant Diseases. The 
aim of this manuscript is to review evidence and rationale for a revision of the current classification, 
to provide a framework for case definition that fully implicates state of the art knowledge and can 
be adapted as new evidence emerges, and to suggest a case definition system that can be 
implemented in clinical practice, research and epidemiologic surveillance. 
Methods: Evidence gathered in 4 commissioned reviews was analyzed and interpreted with special 
emphasis to changes with regards to the understanding available prior to the 1999 classification. 
Authors analyzed case definition systems employed for a variety of chronic diseases and identified 
key criteria for a classification/case definition of periodontitis.  
Results: The manuscript discusses the merits of a periodontitis case definition system based on 
Staging and Grading and proposes a case definition framework. Stage I to IV of periodontitis is 
defined based on severity (primarily periodontal breakdown with reference to root length and 
periodontitis-associated tooth loss), complexity of management (pocket depth, infrabony defects, 
furcation involvement, tooth hypermobility, masticatory dysfunction) and additionally described as 
extent (localized or generalized). Grade of periodontitis is estimated with direct or indirect evidence 
of progression rate in 3 categories: slow, moderate and rapid progression (Grade A-C). Risk factor 
analysis is used as grade modifier.  
Conclusions: The paper describes a simple matrix based on Stage and Grade to appropriately define 
periodontitis in an individual patient. The proposed case definition extends beyond description 
based on severity to include characterization of biological features of the disease and represents a 
first step towards adoption of precision medicine concepts to the management of periodontitis. It 
also provides the necessary framework for introduction of biomarkers in diagnosis and prognosis.  
 
Keywords: Periodontitis, classification, case definition, periodontitis/stage, periodontitis/grade, 
diagnosis, standard of care, clinical attachment loss, radiographic bone loss, periodontal pocket, 
infrabony defect, furcation involvement, tooth hypermobility, masticatory dysfunction, risk factors, 
biomarkers, tooth loss, chronic periodontitis, aggressive periodontitis, necrotizing periodontitis, 
periodontitis as manifestation of systemic disease, stage I periodontitis, stage II periodontitis, stage 
III periodontitis, stage IV periodontitis, Grade A periodontitis, Grade B periodontitis, Grade C 
periodontitis, inflammatory burden. 
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1. Introduction: The 1999 Classification of Periodontitis 
 
Periodontitis is characterized by microbially-associated, host-mediated inflammation that results in 
loss of periodontal attachment. The pathophysiology of the disease has been characterized in its key 
molecular pathways, and ultimately leads to activation of host-derived proteinases that enable loss 
of marginal PDL fibers, apical migration of the junctional epithelium and allows apical spread of the 
bacterial biofilm along the root surface. The bacterial biofilm formation initiates gingival 
inflammation; however periodontitis initiation and progression depend on dysbiotic ecological 
changes in the microbiome in response to nutrients from gingival inflammatory and tissue 
breakdown products that enrich some species and anti-bacterial mechanisms that attempt to 
contain the microbial challenge within the gingival sulcus area once inflammation has initiated. 
Current evidence supports multifactorial disease influences, such as smoking, on multiple immuno-
inflammatory responses that make the dysbiotic microbiome changes more likely for some patients 
than others and likely influence severity of disease for such individuals.  
Marginal alveolar bone loss – a key secondary feature of periodontitis - is coupled with loss of 
attachment by inflammatory mediators.  Clinical presentation differs based on age of patient and 
lesion number, distribution, severity, and location within the dental arch. The level of oral biofilm 
contamination of the dentition also influences the clinical presentation. 
In recent decades, attempts to classify periodontitis have centered on a dilemma represented by 
whether phenotypically different case presentations represent different diseases or just variations of 
a single disease. Lack of ability to resolve the issue is illustrated in the changes to the classification 
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system that progressively emphasized either differences or commonalities.1, 2 Shortly before the 
1999 International Workshop on Classification of periodontal diseases, research in the field 
emphasized individual features of periodontitis and thus differences in phenotype. These emerged 
from the identification of specific bacteria or bacterial complexes as etiologic agents of 
periodontitis,3 the recognition of the existence of multiple modifiable risk factors,4 and the 
identification of the relevance of genetic susceptibility5, 6 and specific polymorphisms associated with 
disease severity.7 The research perspective on the disease impacted the 1999 classification system 
that emphasized perceived unique features of different periodontitis phenotypes and led to the 
recognition of four different forms of periodontitis: 
1. Necrotizing periodontitis 
2. Chronic periodontitis 
3. Aggressive periodontitis 
4. Periodontitis as a manifestation of systemic diseases 
The overall classification system aimed to differentiate the more common forms of periodontitis, i.e. 
chronic and aggressive periodontitis, from the unusual necrotizing form of the disease (characterized 
by a unique pathophysiology, distinct clinical presentation and treatment), and the rare major 
genetic defects or acquired deficiencies in components of host defense (characterized by a primary 
systemic disorder that also expresses itself by premature tooth exfoliation).  
The 1999 group consensus report on aggressive periodontitis identified specific features of this form 
of disease and proposed the existence of major and minor criteria for case definition as well as 
distribution features to differentiate localized from generalized forms of periodontitis.8 By default, 
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cases of periodontitis that would not satisfy the “aggressive” phenotype definition would be 
classified as “chronic” with the implication that latter cases could be managed more easily and, with 
appropriate therapy and maintenance care, would rarely jeopardize the retention of a functional 
dentition.9 The rationale for differentiating between chronic and aggressive periodontitis included 
the ability to identify and focus on the more problematic cases: presenting with greater severity 
earlier in life, at higher risk of progression and/or in need of specific treatment approaches. 
The 1999 International Classification workshop addressed a host of concerns with the 
clinical applicability and pathophysiologic rationale of previous classification systems (see 
Armitage 199910 for discussion), emphasized the need to capture differences between forms 
of the disease able to lead to edentulism, but did not clearly communicate differences 
between chronic and aggressive periodontitis. While the consensus report of the aggressive 
periodontitis working group articulated major and minor criteria required for the aggressive 
periodontitis diagnosis as well as specific definitions to identify patterns of distribution of 
lesions within the dentition (localized molar incisor vs. generalized, see Lang et al. 19998 for 
detailed discussion), the difficulty in applying the stipulated criteria in the everyday clinical 
practice and the substantial overlap between the diagnostic categories provided a barrier to 
clinicians in the application of the classification system. Furthermore, the validity of many of 
the criteria for aggressive periodontitis has not been confirmed in adequately designed 
studies. 
Over the past two decades clinicians, educators, researchers and epidemiologists have voiced 
concern about their ability to correctly differentiate between aggressive and chronic periodontitis 
cases and these difficulties have been a major rationale for a new classification workshop.11 
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2. Summary and Interpretation of Evidence from Current 
Workshop Position Papers 
 
To update evidence that has accumulated since the latest classification workshop, the organizing 
committee commissioned a review on acute periodontal lesions including necrotizing periodontitis,12 
a review of manifestations of systemic diseases that affect the periodontal attachment apparatus,13 
and three position papers that are relevant to the discussion of aggressive and chronic 
periodontitis14 15.16 
The position papers that addressed aggressive and chronic periodontitis reached the following 
overarching conclusions relative to periodontitis: 
1. There is no evidence of specific pathophysiology that enables differentiation of cases that 
would currently be classified as aggressive and chronic periodontitis or provides guidance for 
different interventions. 
2. There is little consistent evidence that aggressive and chronic periodontitis are different 
diseases, but there is evidence of multiple factors, and interactions among them, that 
influence clinically observable disease outcomes (phenotypes) at the individual level. This 
seems to be true for both aggressive and chronic phenotypes. 
3. On a population basis, the mean rates of periodontitis progression are consistent across all 
observed populations throughout the world. 
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4. There is evidence, however, that specific segments of the population exhibit different levels 
of disease progression, as indicated by greater severity of CAL in subsets of each age cohort 
relative to the majority of individuals in the age cohort.  
5. A classification system based only on disease severity fails to capture important dimensions 
of an individual’s disease, including the complexity that influences approach to therapy, the 
risk factors that influence likely outcomes, and level of knowledge and training required for 
managing the individual case. 
 
Authors’ Interpretation of Current Evidence Reviews 
There is sufficient evidence to consider Necrotizing Periodontitis as a separate disease entity. 
Evidence comes from: i) a distinct pathophysiology characterized by prominent bacterial invasion 
and ulceration of epithelium; ii) rapid and full thickness destruction of the marginal soft tissue 
resulting in characteristic soft and hard tissue defects; iii) prominent symptoms; and iv) rapid 
resolution in response to specific antimicrobial treatment. 
There is sufficient evidence to consider that periodontitis observed in the context of 
systemic diseases that severely impair host response should be considered a periodontal 
manifestation of the systemic disease and that the primary diagnosis should be the 
systemic disease according to International Statistical Classification of Disease (ICD).13, 17 
Many of these diseases are characterized by major functional impairment of host defenses 
and have multiple non-oral sequelae. At the moment there is insufficient evidence to 
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consider that periodontitis observed in poorly controlled diabetes is characterized by unique 
pathophysiology and/or requires specific periodontal treatment other than the control of 
both co-morbidities.18  
Despite substantial research on aggressive periodontitis since the 1999 Workshop,14 there is 
currently insufficient evidence to consider aggressive and chronic periodontitis as two 
pathophysiologically distinct diseases.  
Current multifactorial models of disease applied to periodontitis appear to account for a 
substantial part of the phenotypic variation observed across cases as defined by clinical 
parameters. Multiple observational studies in populations with long-term exposure to microbial 
biofilms on the teeth have shown that a small segment of the adult population expresses severe 
generalized periodontitis and most express mild to moderate periodontitis.19, 20 It is also well 
documented using twin studies that a large portion of the variance in clinical severity of periodontitis 
is attributable to genetics.5, 6, 21, 22  
It is reasonable to expect that future research advances will increase our knowledge of disease-
specific mechanisms in the context of the multifactorial biological interactions involved in specific 
phenotypes. That pursuit may be valuable in guiding better management of complex cases and may 
lead to novel approaches that enhance periodontitis prevention, control, and regeneration. Multi-
dimensional profiles that combine biological and clinical parameters are emerging that better define 
phenotypes and may guide deeper understanding of the mechanisms that lead to differences in 
phenotypes.23-26  
There is clinical value in individualizing the diagnosis and the case definition of a periodontitis 
patient to take into account the known dimension of the multifactorial etiology to improve 
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prognosis, account for complexity and risk, and provide an appropriate level of care for the 
individual.  
 
 
3. Integrating Current Knowledge to Advance Classification 
of Periodontitis 
 
3.1 Clinical Definition of Periodontitis  
Periodontitis is characterized by microbially-associated, host-mediated inflammation that results in 
loss of periodontal attachment. This is detected as clinical attachment loss (CAL) by circumferential 
assessment of the erupted dentition with a standardized periodontal probe with reference to the 
cemento-enamel junction.  
It is important to note: 
a. Some clinical conditions other than periodontitis present with clinical attachment loss. 
b. Periodontitis definitions based on marginal radiographic bone loss suffer from severe 
limitations as they are not specific enough and miss detection of mild to moderate 
periodontitis.27 Periodontitis definitions based on radiographic bone loss should be limited 
to the stages of mixed dentition and tooth eruption when clinical attachment level 
measurement with reference to the CEJ are impractical.28 In such cases periodontitis 
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assessments based on marginal radiographic bone loss may use bitewing radiographs taken 
for caries detection. 
 
3.2 Objectives of a Periodontitis Case Definition System  
A case definition system should facilitate the identification, treatment and prevention of 
periodontitis in individual patients. Given current knowledge, a periodontitis case definition system 
should include three components:  
 One that allows identification of a patient as a periodontitis case,  
 A second that identifies the specific form of periodontitis, and  
 A third that describes the clinical presentation and other elements that affect clinical 
management, prognosis, and potentially broader influences on both oral and systemic 
health. 
Furthermore, case definitions may be applied in different contexts: patient care, epidemiological 
surveys and research on disease mechanisms or therapeutic outcomes, as discussed in Appendix B in 
the online Journal of Periodontology. In the various contexts, case definitions may require different 
diagnostic characteristics based on the objectives of the specific application, as is discussed below. 
 
3.3 Definition of a Patient as a Periodontitis Case 
 Version 9.0 
 
This article is protected by copyright. All rights reserved. 
Page 11 of 41 
 
Given the measurement error of clinical attachment level with a standard periodontal probe, a 
degree of misclassification of the initial stage of periodontitis is inevitable and this affects diagnostic 
accuracy. As disease severity increases, clinical attachment loss is more firmly established, and a 
periodontitis case can be identified with greater accuracy. Decreasing the threshold of CAL increases 
sensitivity. Increasing the threshold, requiring CAL at more than one site, and excluding causes of 
CAL, other than periodontitis, increases specificity.  
We should anticipate that, until more robust methods, potentially salivary biomarkers or novel soft-
tissue imaging technologies, are validated, the level of training and experience with periodontal 
probing will greatly influence the identification of a case of initial periodontitis.  
It should be noted that periodontal inflammation, generally measured as bleeding on probing (BOP), 
is an important clinical parameter relative to assessment of periodontitis treatment outcomes and 
residual disease risk post-treatment.29-32 However BOP itself, or as a secondary parameter with CAL, 
does not change the initial case definition as defined by CAL or change the classification of 
periodontitis severity.  
Multiple periodontitis case definitions have been proposed in recent years. The AAP/CDC 
case definition for epidemiologic surveillance and the EFP case definition for the purpose of 
risk factors research have been widely utilized.33, 34 Although the AAP/CDC and the sensitive 
EFP definition share similarities there are some important differences.   
In the context of the 2017 World Workshop it is suggested that a single definition be adopted.  
A patient is a periodontitis case in the context of clinical care if: 
1. Interdental CAL is detectable at 2 or more non-adjacent teeth, or 
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2. Buccal or oral CAL ≥ 3mm with pocketing greater than 3 mm is detectable at 2 or more 
teeth  
but the observed CAL cannot be ascribed to non-periodontal causes such as: i) gingival recession of 
traumatic origin; ii) dental caries extending in the cervical area of the tooth; iii) the presence of CAL 
on the distal aspect of a second molar and associated with malposition or extraction of a third molar, 
iv) an endodontic lesion draining through the marginal periodontium; and v) the occurrence of a 
vertical root fracture.  
Key to periodontitis case definition is the notion of “detectable” interdental CAL: the clinician being 
able to specifically identify areas of attachment loss during periodontal probing or direct visual 
detection of the interdental CEJ during examination, taking measurement error and local factors into 
account. 
It is recognized that “detectable” interdental attachment loss may represent different magnitudes of 
CAL based upon the skills of the operator (e.g. specialist or general practitioner) and local conditions 
that may facilitate or impair detection of the CEJ, most notably the position of the gingival margin 
with respect to the CEJ, the presence of calculus or restorative margins. The proposed case 
definition does not stipulate a specific threshold of detectable CAL to avoid misclassification of initial 
periodontitis cases as gingivitis and maintain consistency of histological and clinical definitions. 
There is also a need to increase specificity of the definition and this is accomplished requiring 
detection of CAL at two non-adjacent teeth. Setting a specific threshold of CAL for periodontitis 
definition (e.g. 2 mm) to address measurement error with CAL detection with a periodontal probe 
would result in misclassification of initial periodontitis cases as gingivitis. Specific considerations are 
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needed for epidemiological surveys where threshold definition is likely to be based on numerical 
values dependent on measurement errors. 
 
3.4 Identification of the Form of Periodontitis 
Based on pathophysiology, three clearly different forms of periodontitis have been identified: 
A. Necrotizing periodontitis 
B. Periodontitis as a direct manifestation of systemic diseases 
C. Periodontitis  
Differential diagnosis is based on history and the specific sign and symptoms of necrotizing 
periodontitis and the presence or absence of an uncommon systemic disease that definitively alters 
the host immune response. Necrotizing periodontitis is characterized by history of pain, presence of 
ulceration of the gingival margin and/or fibrin deposits at sites with characteristically decapitated 
gingival papillae, and, in some cases, exposure of the marginal alveolar bone. With regards to 
periodontitis as a direct manifestation of systemic disease, the recommendation is to follow the 
classification of the primary disease according to the respective International Statistical Classification 
of Diseases and Related Health Problems (ICD) codes. 
The vast majority of clinical cases of periodontitis do not have the local characteristics of necrotizing 
periodontitis or the systemic characteristics of a rare immune disorder with a secondary 
manifestation of periodontitis. It is the majority of clinical cases of periodontitis that present with a 
range of phenotypes that require different approaches to clinical management and offer different 
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complexities that define the knowledge and experience necessary to successfully manage various 
cases. 
 
3.5 Additional Elements Proposed for Inclusion in the Classification 
of Periodontitis 
Since the 1999 International Classification Workshop, it has become apparent that additional 
information beyond the specific form of periodontitis and the severity and extent of periodontal 
breakdown is necessary to more specifically characterize the impact of past disease on an individual 
patient’s dentition and on treatment approaches needed to manage the case. Clinical diagnosis 
needs to be more all-encompassing in expressing the effects of periodontitis and should account not 
only for the oral effects but also for potential systemic implications of the disease. 
Severity 
The degree of periodontal breakdown present at diagnosis has long been used as the key 
descriptor of the individual case of periodontitis. The 1999 case definition system is also 
based on severity. Rationale of classification according to severity encompasses at least two 
important dimensions: complexity of management and extent of disease. Important 
limitations of severity definitions are worth discussing also in the context of recent 
therapeutic improvements that have enabled successful management of progressively more 
severe periodontitis.35 Conventional definitions of severe periodontitis need to be revised to 
better discriminate the more severe forms of periodontitis. Another important limitation of 
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current definitions of severe periodontitis is a paradox: whenever the worst affected teeth 
in the dentition are lost, severity may actually decrease. Tooth loss attributable to 
periodontitis needs to be incorporated in the definition of severity. 
Complexity of management 
Factors such as probing depths,36 type of bone loss (vertical and/or horizontal),37 furcation 
status,38 tooth mobility,39-41 missing teeth, bite collapse,42 and residual ridge defect size, 
increase treatment complexity, need to be considered and should ultimately influence 
diagnostic classification. Explicit designation of case complexity factors help define level of 
competence and experience that a case is likely to require for optimal outcomes. 
Extent  
The number and the distribution of teeth with detectable periodontal breakdown has been part of 
current classification systems. The number of affected teeth (as a percentage of teeth present) has 
been used to define cases of chronic periodontitis in the 1999 classification9, 10 while the distribution 
of lesions (molar incisor vs generalized pattern of breakdown) has been used as a primary descriptor 
for aggressive periodontitis.8, 28 Rationale for keeping this information in the classification system 
comes from the fact that specific patterns of periodontitis (e.g. the molar-incisor pattern of younger 
subjects presenting with what was formerly called localized juvenile periodontitis, provide indirect 
information about the specific host-biofilm interaction.  
Rate of progression  
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One of the most important aspects for a classification system is to properly account for variability in 
the rate of progression of periodontitis. The importance of this criteria has been well recognized in 
the 1989 AAP classification that identified a rapidly progressing form of periodontitis.43 Concern 
about this criterion has been mostly on how to assess the rate of progression at initial examination 
in the absence of direct evidence (e.g. an older diagnostic quality radiograph allowing comparison of 
marginal bone loss over time). 
Risk Factors 
Recognized risk factors have not been previously included formally in the classification system of 
periodontitis but have been used as a descriptor to qualify the specific patient as a smoker or a 
patient with diabetes mellitus. Improved knowledge of how risk factors affect periodontitis (higher 
severity and extent at an earlier age) and treatment response (smaller degrees of improvements in 
surrogate outcomes and higher rates of tooth loss during supportive periodontal therapy40, 41, 44 
indicate that risk factors should be considered in the classification of periodontitis. 
Interrelationship with general health 
Since the 1999 workshop considerable evidence has emerged concerning potential effects of 
periodontitis on systemic diseases. Various mechanisms linking periodontitis to multiple systemic 
diseases have been proposed.45, 46 Specific oral bacteria in the periodontal pocket may gain 
bloodstream access through ulcerated pocket epithelium. Inflammatory mediators from the 
periodontium may enter the bloodstream and activate liver acute phase proteins, such as C-reactive 
protein (CRP), which further amplify systemic inflammation levels. Case-control47-50 and pilot 
intervention studies51, 52 show that periodontitis contributes to the overall inflammatory burden of 
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the individual which is strongly implicated in coronary artery disease, stroke and Type 2 diabetes.53-58 
Initial evidence also supports the potential role of overall systemic inflammatory burden on risk for 
periodontitis.59 
Modestly sized periodontitis treatment studies of uncontrolled Type 2 diabetes have shown 
value in reducing hyperglycemia, although reductions in hyperglycemia have not been 
supported in some larger studies where the periodontal treatment outcomes were less 
clear.18, 60, 61 Although intriguing health economics analyses have shown a reduction in cost 
of care for multiple medical conditions following treatment for periodontitis,62 little direct 
periodontitis intervention evidence, beyond the diabetes experience, has convincingly 
demonstrated the potential value of effectively treating periodontitis relative to overall 
health benefits. Current evidence that effective treatment of certain cases of periodontitis 
can favorably influence systemic diseases or their surrogates, although limited, is 
intriguing and should be definitively assessed. 
Other factors that need to be considered in formulating a diagnostic classification include the 
medical status of the patient and the level of expertise needed to provide appropriate care. If the 
patient has severe systemic disease, as indicated by their American Society of Anesthesiologists 
(ASA) status, this can seriously affect the clinician’s ability to control disease progression due to the 
patient’s inability to withstand proper treatment or their inability to attend necessary maintenance 
care. 
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4. Framework for Developing a Periodontitis Staging and 
Grading System 
 
New technologies and therapeutic approaches to periodontitis management are now available such 
that clinicians with advanced training can manage moderate and severe periodontitis patients to 
achieve clinical outcomes that were not previously possible.  
The other dimension not previously available in our classification is the directed identification of 
individual patients who are more likely to require greater effort to prevent or control their chronic 
disease long-term. This explicitly acknowledges the evidence that most individuals and patients 
respond predictably to conventional approaches to prevent periodontitis and conventional 
therapeutic approaches and maintenance, while others may require more intensive and more 
frequent preventive care or therapeutic interventions, monitoring and maintenance.19, 20, 63-65  
Staging, an approach used for many years in oncology, has been recently discussed relative 
to periodontal disease66 and affords an opportunity to move beyond the one-dimensional 
approach of using past destruction alone and furnishes a platform on which a 
multidimensional diagnostic classification could be built. Furthermore, a uniform staging 
system should provide a way of defining the state of periodontitis at various points in time, 
can be readily communicated to others to assist in treatment, and may be a factor in 
assessing prognosis. Periodontitis staging should assist clinicians in considering all relevant 
dimensions that help optimize individual patient management and thus represents a critical 
step towards personalized care (or precision medicine).  
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Staging relies on the standard dimensions of severity and extent of periodontitis at presentation but 
introduces the dimension of complexity of managing the individual patient.  
As it is recognized that subjects presenting with different severity/extent and resulting complexity of 
management may present different rates of progression of the disease and/or risk factors, the 
information derived from the staging of periodontitis should be supplemented by information on the 
inherent biological grade of the disease. This relies on three sets of parameters: i) rate of 
periodontitis progression; ii) recognized risk factors for periodontitis progression; and iii) risk of an 
individual’s case affecting the systemic health of the subject.  
The concept and value of “staging” has been extensively developed in the oncology field. Staging of 
tumors is based on current observable clinical presentation including size or extent and whether it 
has metastasized. This may be an example of how one might communicate current severity and 
extent of a disease, as well as the clinical complexities of managing the case. To supplement staging, 
that provides a summary of clinical presentation, grade has been used as an assessment of the 
potential for a specific tumor to progress, i.e. to grow and spread, based on microscopic appearance 
of tumor cells. In addition, current molecular markers often guide selection of specific drug 
therapies, and thereby incorporate biological targets that increase the granularity of the grade and 
thus may increase the probability of a favorable clinical outcome. These concepts have been 
adapted to periodontitis, as summarized in Table 1, and as described in detail below. 
While devising a general framework, it seems relevant from a patient management standpoint to 
differentiate four stages of periodontitis. Each of these stages is defined by unique disease 
presentation in terms of disease severity and complexity of management. In each stage of severity, it 
may be useful to identify subjects with different rates of disease progression and it is foreseen that, 
 Version 9.0 
 
This article is protected by copyright. All rights reserved. 
Page 20 of 41 
 
in the future, stage definition will be enriched by diagnostic tests enabling definition of the biological 
“grade” and/or susceptibility of periodontitis progression in the individual patient. The addition of 
grade may be achieved by refining each subject’s stage definition with a Grade A, B or C, in which 
increasing grades will refer to subjects with direct or indirect evidence of different rates of 
periodontal breakdown and presence and level of control of risk factors. 
An individual case may thus be defined by a simple matrix of Stage at presentation (severity and 
complexity of management) and Grade (evidence or risk of progression and potential risk of systemic 
impact of the patient’s periodontitis; these also influence the complexity of management of the 
case). Table 2 illustrates this concept and provides a general framework that will allow update and 
revisions over time as specific evidence becomes available to better define individual components, 
particularly in the biological grade dimension of the disease and the systemic implications of 
periodontitis. 
Stage I Periodontitis 
Stage I Periodontitis is the borderland between gingivitis and periodontitis and represents the early 
stages of attachment loss. As such, subjects with Stage I Periodontitis have developed periodontitis 
in response to persistence of gingival inflammation and biofilm dysbiosis. They represent more than 
just an early diagnosis: if they show a degree of clinical attachment loss at a relatively early age, 
these subjects may have heightened susceptibility to disease onset. Early diagnosis and definition of 
a population of susceptible subjects offers opportunities for early intervention and monitoring that 
may prove more cost-effective at the population level as shallow lesions may provide specific 
options for both conventional mechanical biofilm removal and pharmacological agents delivered in 
oral hygiene aids. It is recognized that early diagnosis may be a formidable challenge in general 
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dental practice as periodontal probing to estimate early clinical attachment loss – the current gold 
standard for defining periodontitis – may be inaccurate. Assessment of salivary biomarkers and/or 
new imaging technologies may increase early detection of Stage I Periodontitis in a variety of 
settings.  
Stage II Periodontitis 
Stage II Periodontitis represents the stage of established periodontitis in which a carefully performed 
clinical periodontal examination identifies the characteristic damages that periodontitis has caused 
to tooth support. At this stage of the disease process, however, management remains relatively 
simple for many cases as application of standard treatment principles involving regular personal and 
professional bacterial removal and monitoring is expected to arrest disease progression at this stage. 
Careful evaluation of the Stage II patient’s response to standard treatment principles is essential, 
and the case Grade plus treatment response may guide more intensive management for specific 
patients.  
Stage III Periodontitis 
At Stage III, periodontitis has produced significant damage to the attachment apparatus and, in the 
absence of advanced treatment, some teeth may be at risk of being lost. The stage is characterized 
by the presence of deep periodontal lesions that extend to the middle portion of the root whose 
management is complicated by the presence of deep intrabony defects, furcation involvement, 
history of periodontal tooth loss/exfoliation, presence of localized ridge defects that complicate 
implant tooth replacement. In spite of the possibility of tooth loss, masticatory function is preserved, 
and treatment of periodontitis does not require complex rehabilitation of function. 
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Stage IV Periodontitis 
At the more advanced Stage IV, periodontitis has caused considerable damage to the periodontal 
support and may have caused significant tooth loss; this translates in loss of masticatory function. In 
the absence of proper control of the periodontitis and adequate rehabilitation, the dentition is at 
risk of being lost. 
This stage is characterized by the presence of deep periodontal lesions that extend to the apical 
portion of the root and/or history of multiple tooth loss; it is frequently complicated by tooth 
hypermobility due to secondary occlusal trauma and the sequelae of tooth loss: posterior bite 
collapse and drifting. Frequently, case management requires stabilization/restoration of masticatory 
function. 
Grade of Periodontitis 
 
Irrespective of the Stage at diagnosis, periodontitis may progress with different rates in individual 
subjects, may respond less predictably to treatment in some patients, and may or may not influence 
general health or systemic disease. This information is critical for precision medicine but has been an 
elusive objective to achieve in clinical practice.  In recent years, validated risk assessment tools,25, 67 
and presence of any one of three individually validated risk factors65 have been associated with 
tooth loss, indicating that it is possible to estimate risk of periodontitis progression and tooth loss.  
In the past, grade of periodontitis progression has been incorporated into the classification system 
by defining specific forms of periodontitis with high(er) rates of progression or presenting with more 
severe destruction relatively early in life.28 One major limitation in the implementation of this 
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knowledge has been the assumption that such forms of periodontitis represent different entities and 
thus focus has been placed on identification of the form rather than the factors contributing to 
progression. The systematic reviews informing this workshop have indicated that there is no 
evidence to suggest that such forms of periodontitis have a unique pathophysiology, rather the 
complex interplay of risk factors in a multifactorial disease model may explain the phenotypes of 
periodontitis in exposed patients. In this context, it seems useful to provide a framework for 
implementation of biological grade (risk or actual evidence of progression) of periodontitis in the 
individual patient.  
Recognized risk factors, such as cigarette smoking or metabolic control of diabetes, affect the rate of 
progression of periodontitis and, consequently, may increase the conversion from one stage to the 
next. Emerging risk factors like obesity, specific genetic factors, physical activity or nutrition may one 
day contribute to assessment and a flexible approach needs to be devised to ensure that the case-
definition system will adapt to the emerging evidence. 
Disease severity at presentation/diagnosis as a function of patient age has also been an 
important indirect assessment of the level of individual susceptibility. While not ideal – as it 
requires significant disease at early age or minimal disease at advanced age – this concept 
has been used in clinical practice and risk assessment tools to identify highly susceptible or 
relatively resistant individuals. One approach has been the assessment of bone loss in 
relation to patient age by measuring radiographic bone loss in percentage of root length 
divided by the age of the subject. This approach was originally applied in a longitudinal 
assessment of disease progression assessed in intraoral radiographs68, 69 and was later 
incorporated in the theoretical concept that led to development of the periodontal risk 
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assessment (PRA) system.31, 70 More recently, an individual’s severity of CAL has been 
compared to their age cohort.16 This information from large and diverse populations could 
be considered an age standard for CAL, with the assumption that individuals who exceed the 
mean CAL threshold for a high percentile in the age cohort would be one additional piece of 
objective information that may represent increased risk for future progression. The CAL 
must be adjusted in some way based on number of missing teeth to avoid biasing the CAL 
based on measuring only remaining teeth after extraction of the teeth with the most severe 
periodontitis.  Such challenges again require a framework that will adapt to change as more 
precise ways to estimate individual susceptibility become available. 
Integrating Biomarkers in a Case Definition System 
Clinical parameters are very effective tools for monitoring the health-disease states in most patients, 
likely because they respond favorably to the key principles of periodontal care, which include regular 
disruption, and reduction of the gingival and subgingival microbiota.  Current evidence suggests, 
however, that some individuals are more susceptible to develop periodontitis; more susceptible to 
develop progressive severe generalized periodontitis; less responsive to standard bacterial control 
principles for preventing and treating periodontitis; and theoretically more likely for their 
periodontitis to adversely impact systemic diseases.   
If due to multiple factors, such individuals are more likely than others to develop and maintain a 
dysbiotic microbiota in concert with chronic periodontal inflammation, it is unclear whether current 
clinical parameters are sufficient to monitor disease development and treatment responses in such 
patients. For those individuals, biomarkers, some of which are currently available, may be valuable 
to augment information provided by standard clinical parameters.  
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Biomarkers may contribute to improved diagnostic accuracy in the early detection of periodontitis 
and are likely to provide decisive contributions to a better assessment of the Grade of periodontitis. 
They may assist both in staging and grading of periodontitis. The proposed framework allows 
introduction of validated biomarkers in the case definition system. 
Integrating Knowledge of the Interrelationship between Periodontal Health 
and General Health in a Case Definition System 
At present there is only emerging evidence to identify specific periodontitis cases in which 
periodontal treatment produces general health benefits. it is important to identify approaches to 
capture some dimensions of the potential systemic impact of a specific periodontitis case and its 
treatment to provide the basis for focusing attention on this issue and beginning to collect evidence 
necessary to assess whether effective treatment of certain cases of periodontitis truly influence 
systemic disease in a meaningful way.  
 
Specific considerations for use of the Staging and Grading of Periodontitis with epidemiological and 
research applications are discussed in Appendix B in the online Journal of Periodontology. 
 
5. Incorporation of Staging and Grading in the Case 
Definition System of Periodontitis 
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A case definition system needs to be a dynamic process that will require revisions over time in much 
the same way the tumor, node, metastasis (TNM) staging system for cancer has been shaped over 
many decades. It needs to be: 
i) Simple enough to be clinically applicable but not simplistic: additional knowledge has 
distinguished dimensions of periodontitis, such as complexity of managing the case to 
provide the best level of care 
ii) Standardized in order to be able to support effective communication among all 
stakeholders 
iii) Accessible to a wide range of people in training and understood by members of the oral 
health care team around the world 
It is suggested that a case definition based on a matrix of periodontitis stage and periodontitis grade 
be adopted. Such multidimensional view of periodontitis would create the potential to transform 
our view of periodontitis. And the powerful outcome of that multidimensional view is the ability to 
communicate better with patients, other professionals, and third parties. 
Stage of Periodontitis (Table 3) 
At present, relevant data are available to assess the two dimensions of the Staging process: severity 
and complexity. These can be assessed in each individual case at diagnosis by appropriate 
anamnestic, clinical and imaging data.  
The severity score is primarily based on interdental CAL in recognition of low specificity of both 
pocketing and marginal bone loss, although marginal bone loss is also included as an additional 
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descriptor. It follows the general frame of previous severity based scores and is assigned based on 
the worst affected tooth in the dentition. Only attachment loss attributable to periodontitis is used 
for the score.  
The complexity score is based on the local treatment complexity assuming the wish/need to 
completely eliminate local factors and takes into account factors like presence of vertical defects, 
furcation involvement, tooth hypermobility, drifting and/or flaring of teeth, tooth loss, ridge 
deficiency and loss of masticatory function. Besides the local complexity, it is recognized that 
individual case management may be complicated by medical factors or comorbidities. 
The diagnostic classification presented in Table 3 provides definitions for four stages of periodontitis. 
In using the table, it is important to use clinical attachment loss as the initial Stage determinant in 
the Severity dimension. It is recognized that in clinical practice application some clinicians may 
prefer to use diagnostic quality radiographic imaging as an indirect and somehow less sensitive 
assessment of periodontal breakdown. This may be all that is necessary to establish the stage. 
However, if other factors are present in the Complexity dimension that influence the disease then 
modification of the initial stage assignment may be required. For example, in case of very short 
common root trunk a CAL of 4 mm may have resulted in class II furcation involvement, hence shifting 
the diagnosis from Stage II to Stage III periodontitis. Likewise, if posterior bite collapse is present 
then the Stage IV would be the appropriate Stage diagnosis since the complexity is on the Stage IV 
level. 
Evidence for defining different stages based on CAL loss/bone loss in relation to root length is 
somewhat arbitrary.  
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Patients who have been treated for periodontitis may be periodically staged to monitor them. In 
most of successfully treated patients, complexity factors that might have contributed to baseline 
staging will have been resolved through treatment. In such patients CAL and RBL will be the primary 
stage determinants. If a stage shifting complexity factor(s) were eliminated by treatment, the stage 
should not retrogress to a lower stage since the original stage complexity factor should always be 
considered in maintenance phase management. A notable exception is successful periodontal 
regeneration that may, through improvement of tooth support, effectively improve CAL and RBL of 
the specific tooth. 
 
Grade of Periodontitis (Table 4) 
Grading adds another dimension and allows rate of progression to be considered. Table 4 illustrates 
periodontitis grading based on primary criteria represented by the availability of direct or indirect 
evidence of periodontitis progression. Direct evidence is based on longitudinal observation available 
for example in the form of older diagnostic quality radiographs. Indirect evidence is based on the 
assessment of bone loss at the worst affected tooth in the dentition as a function of age (measured 
as radiographic bone loss in percentage of root length divided by the age of the subject). 
Periodontitis grade can then be modified by the presence of risk factors.  
The objective of grading is to use whatever information is available to determine the likelihood of 
the case progressing at a greater rate than is typical for the majority of the population or responding 
less predictably to standard therapy.  
Clinicians should approach grading by assuming a moderate rate of progression (Grade B) and look 
for direct and indirect measures of actual progression in the past as a means of improving the 
establishment of prognosis for the individual patient. If the patient has risk factors that have been 
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associated with more disease progression or less responsiveness to bacterial reduction therapies, 
the risk factor information can be used to modify the estimate of the patient’s future course of 
disease. A risk factor, should therefore shift the grade score to a higher value independently of the 
primary criterion represented by the rate of progression. For example, a Stage and Grade case 
definition could be characterized by moderate attachment loss (Stage II), the assumption of 
moderate rate of progression (Grade B) modified by the presence of poorly controlled Type II 
diabetes (a risk factor that is able to shift the Grade definition to rapid progression or Grade C).  
In summary a periodontitis diagnosis for an individual patient should encompass 3 dimensions: 
1. Definition of a periodontitis case based on detectable CAL loss at two non-adjacent teeth 
2. Identification of the form of periodontitis: necrotizing periodontitis, periodontitis as a 
manifestation of systemic disease or periodontitis 
3. Description of the presentation and aggressiveness of the disease by Stage and Grade (see 
Appendix A in online Journal of Periodontology) 
 
6. Conclusions 
 
The proposed Staging and Grading of periodontitis provides an individual patient assessment that 
classifies patients by two dimensions beyond severity and extent of disease that identify patients as 
to complexity of managing the case and risk of the case exhibiting more progression and/or 
responding less predictably to standard periodontal therapy. The proposed risk stratification is based 
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on well-validated risk factors including smoking, uncontrolled Type 2 diabetes, clinical evidence of 
progression or disease diagnosis at an early age, and severity of bone loss relative to patient age.  
The proposed Staging and Grading explicitly acknowledges the potential for some cases of 
periodontitis to influence systemic disease. The current proposal does not intend to minimize the 
importance or extent of evidence supporting direct distal effects of periodontal bacteremia on 
adverse pregnancy outcomes and potentially other systemic conditions; but focuses on the role of 
periodontitis as the second most frequent factor (obesity being the most frequent) that is well-
documented as a modifiable contributor to systemic inflammatory burden.  
The proposed staging and grading is designed to avoid the paradox of improvement of disease 
severity observed after loss/extraction of the more compromised teeth. This is achieved by 
incorporating, whenever available, knowledge about periodontitis being the predominant reason for 
loss of one or more teeth. 
Finally, one of the strong benefits of the Staging and Grading of Periodontitis is that it is designed to 
accommodate regular review by an ad hoc international task force to ensure that the framework 
incorporates relevant new knowledge within an already functioning clinical application. 
 
 
 
Table 1. Primary Goals in Staging and Grading a Periodontitis Patient 
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Table 2 – Framework for Staging and Grading of Periodontitis 
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  Disease Severity and Complexity of Management 
  Stage I 
Initial Periodontitis 
Stage II  
Moderate 
Periodontitis 
Stage III 
Severe Periodontitis 
with potential for 
additional tooth 
loss 
Stage IV 
Advanced Periodontitis 
with extensive tooth 
loss and potential for 
loss of dentition 
Evidence or risk of rapid 
progression, anticipated 
treatment response and 
effects on systemic health 
Grade A Individual Stage and Grade Assignment 
Grade B 
Grade C 
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Table 3 – Periodontitis Stage – Please see text and appendix A (in online 
Journal of Periodontology) for explanation 
Periodontitis stage  
 
Stage I Stage II Stage III Stage IV 
Severity  Interdental 
CAL at site 
of greatest 
loss 
1-2 mm 3-4 mm ≥ 5 mm  ≥ 8 mm  
 Radiographic 
bone loss 
Coronal third (< 
15%) 
Coronal third 
(15-33%) 
Extending to Middle 
third 
Extending to Apical third 
 Tooth loss No Perio Tooth Loss Perio tooth loss ≤ 4 
teeth 
Perio tooth loss ≥ 5 
teeth 
Complexity Local Probing depth < 
4mm 
Mostly 
horizontal bone 
loss 
 
Probing depth < 
5mm 
Mostly horizontal 
bone loss 
 
In addition to Stage II 
Complexity: Probing 
depth 6-7mm 
Vertical bone loss ≥ 3 
Furcation II or III 
Moderate ridge defect 
In addition to Stage III 
Complexity, Need for 
complex rehabilitation 
due to: Masticatory 
dysfunction 
Secondary occlusal 
trauma  
(Tooth mobility ≥ 2) 
Bite collapse, drifting, 
flaring 
Less than 20 remaining 
teeth  
(10 opposing pairs);  
Probing depth > 8mm 
Severe ridge defect 
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Extent & 
distribution 
Add to Stage 
as descriptor 
For each Stage, describe extent as localized (<30% of teeth involved), generalized or molar 
incisor pattern 
 
The initial Stage should be determined using CAL; if not available then RBL should be used. Information on 
tooth loss that can be attributed primarily to periodontitis – if available – may modify stage definition. This is 
the case even in the absence of complexity factors. Complexity factors may shift the Stage to a higher level, for 
example furcation II or III would shift to either Stage III or IV irrespective of the CAL. The distinction between 
Stage III and Stage IV is primarily based on complexity factors. For example, a high level of tooth mobility 
and/or posterior bite collapse would indicate a Stage IV diagnosis. For any given case only some, not all, 
complexity factors may be present, however, in general it only takes 1 complexity factor to shift the diagnosis 
to a higher Stage. It should be emphasized that these case definitions are guidelines that should be applied 
using sound clinical judgment to arrive at the most appropriate clinical diagnosis. 
For post-treatment patients CAL and RBL are still the primary stage determinants. If a stage shifting complexity 
factor(s) were eliminated by treatment, the stage should not retrogress to a lower stage since the original 
stage complexity factor should always be considered in maintenance phase management.  
 
Abbreviations: CAL – clinical attachment loss; RBL = radiographic bone loss. 
 
Table 4 – Periodontitis Grade – Please see text and appendix A (in online 
Journal of Periodontology) for explanation 
 
Periodontitis Grade  
 
Grade A 
Slow rate of 
progression  
Grade B 
Moderate rate 
of progression 
Grade C 
Rapid rate of progression 
Primary 
Criteria 
Direct 
evidence of 
progression 
Longitudinal 
data (PA 
radiographs 
or CAL loss) 
Evidence of no 
loss  
over 5 years 
 
<2 mm over 5 
years 
 
 
≥ 2 mm over 5 years 
 
Indirect 
evidence of 
progression 
Bone 
loss/age 
 
< 0.25 
 
0.25-1.0 
 
> 1.0 
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Case 
phenotype 
Heavy biofilm 
deposits with 
low levels of 
destruction 
Destruction 
commensurate 
with biofilm 
deposits  
Destruction exceeds expectation 
given biofilm deposits; Specific 
clinical patterns suggestive of 
periods of rapid progression 
and/or Early onset disease … 
e.g. Molar incisor pattern; Lack 
of expected response to 
standard bacterial control 
therapies 
Grade 
modifiers  
Risk Factors Smoking 
 
Diabetes 
Non-Smoker 
 
Normoglycaemic 
with or without 
prior diagnosis 
of diabetes 
Smoker <10 
cigarettes/day 
 
HbA1c < 7.0 in 
diabetes 
patient  
Smoker ≥10 cigarettes/day  
 
HbA1c ≥ 7.0 in diabetes patient 
 
Risk of 
systemic 
impact of 
periodontitis* 
Inflammatory 
Burden 
High 
sensistivity 
CRP (hsCRP) 
< 1 mg/L 1-3 mg/L > 3 mg/L 
Biomarkers Indicators of 
CAL/bone 
loss 
Saliva, GCF, 
serum 
? ? ? 
 
Grade should be used as an indicator of the rate of periodontitis progression. The primary criteria are either 
direct or indirect evidence of progression. Whenever available, direct evidence is used; in its absence indirect 
estimation is made using bone loss as a function of age at the most affected tooth or case presentation 
(radiographic bone loss expressed as percentage of root length divided by the age of the subject, RBL/age). 
Clinicians should initially assume Grade B disease and seek specific evidence to shift towards grade A or C, if 
available. Once grade is established based on evidence of progression, it can be modified based on the 
presence of risk factors.  
*Refers to Increased risk that periodontitis may be an inflammatory co-morbidity for the specific patient. CRP values 
represent a summation of the patient’s overall systemic inflammation, which may be in part influenced by periodontitis, 
but otherwise is an “unexplained” inflammatory burden that be valuable to assess in collaboration with the patient’s 
physicians. The grey color of the table cells refers to the need to substantiate with specific evidence. This element is placed 
in the table to draw attention to this dimension of the biology of periodontitis. It is envisaged that in the future it will be 
possible integrate the information into periodontitis Grade to highlight the potential of systemic impact of the disease in 
the specific case. 
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